메뉴 건너뛰기




Volumn 11, Issue 11 SUPPL. 11A, 1997, Pages 223-227

The ASGO Experience With Evidence-Based Clinical Practice Guidelines

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR; TUMOR MARKER;

EID: 0031264937     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (14)

References (10)
  • 1
    • 0030118021 scopus 로고    scopus 로고
    • The American Society of Clinical Oncology guideline program
    • Winn RJ, Smith TJ: The American Society of Clinical Oncology guideline program. Pharm Practice Management Q 16:31-38, 1996.
    • (1996) Pharm Practice Management Q , vol.16 , pp. 31-38
    • Winn, R.J.1    Smith, T.J.2
  • 2
    • 9044233642 scopus 로고    scopus 로고
    • Outcomes of cancer treatment for technology assessment and cancer treatment guidelines
    • American Society of Clinical Oncology Outcomes Working Group: Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. J Clin Oncol 14:671-679, 1996.
    • (1996) J Clin Oncol , vol.14 , pp. 671-679
  • 3
    • 0028036827 scopus 로고
    • American Society of Clinical Oncology recommendations for the use of hematopoietic colony-stimulating factors: Evidence-based, clinical practice guidelines
    • ASCO Ad Hoc Colony-stimulating factor Guidelines Expert Panel: American Society of Clinical Oncology recommendations for the use of hematopoietic colony-stimulating factors: Evidence-based, clinical practice guidelines. J Clin Oncol 12:2471-2508, 1994.
    • (1994) J Clin Oncol , vol.12 , pp. 2471-2508
  • 4
    • 0344405536 scopus 로고    scopus 로고
    • American Society of Clinical Oncology update of recommendations for the use of hematopoietic colony-stimulating factors: Evidence-based, clinical practice guidelines
    • Ozer H, Miller LL, Schiffer CA, et al: American Society of Clinical Oncology update of recommendations for the use of hematopoietic colony-stimulating factors: Evidence-based, clinical practice guidelines. J Clin Oncol 14:1957-1960, 1996.
    • (1996) J Clin Oncol , vol.14 , pp. 1957-1960
    • Ozer, H.1    Miller, L.L.2    Schiffer, C.A.3
  • 6
    • 10144258654 scopus 로고    scopus 로고
    • Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer
    • ASCO Tumor Marker Expert Panel: Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. J Clin Oncol 14:2843-2877, 1996.
    • (1996) J Clin Oncol , vol.14 , pp. 2843-2877
  • 7
    • 0030963119 scopus 로고    scopus 로고
    • Recommended breast cancer surveillance guidelines
    • Breast cancer surveillance expert panel: Recommended breast cancer surveillance guidelines. J Clin Oncol 15:2149-2156, 1997.
    • (1997) J Clin Oncol , vol.15 , pp. 2149-2156
  • 8
    • 0030836373 scopus 로고    scopus 로고
    • American Society of Clinical Oncology Expert Panel on Treatment of Unresectable Non-Small-Cell Lung cancer: J Clin Oncol 15:2996-3018, 1997.
    • (1997) J Clin Oncol , vol.15 , pp. 2996-3018
  • 9
    • 0029097248 scopus 로고
    • Does knowledge guide practice? Another look at the management of non small cell lung cancer
    • Raby B, Pater J, Mackillop WJ: Does knowledge guide practice? Another look at the management of non small cell lung cancer. J Clin Oncol 13:1904-1911, 1995.
    • (1995) J Clin Oncol , vol.13 , pp. 1904-1911
    • Raby, B.1    Pater, J.2    Mackillop, W.J.3
  • 10
    • 0029764366 scopus 로고    scopus 로고
    • Use of hematopoietic colony stimulating factors: The American Society of Clinical Oncology survey
    • Bennett C, Smith T, Weeks J, et al: Use of hematopoietic colony stimulating factors: The American Society of Clinical Oncology survey. J Clin Oncol 14:2511-2520, 1996.
    • (1996) J Clin Oncol , vol.14 , pp. 2511-2520
    • Bennett, C.1    Smith, T.2    Weeks, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.